FUT1-mediated terminal fucosylation acts as a new target to attenuate renal fibrosis.

Jialiang LuoKaifeng MaoZhengyumeng ZhuJunli YeLei LiDi WangJia ZhouFenwang LinJuan LiJunsheng Ye

Published in: Molecular medicine (Cambridge, Mass.) (2023)

The development of kidney fibrosis is attributed to FUT1-mediated terminal fucosylation, shedding light on the inhibition of terminal fucosylation as a potential therapeutic treatment against renal fibrosis.

Keyphrases

liver fibrosis
replacement therapy